Clinical Trial

Radiofrequency Ablation For Recurrent Parathyroid Carcinoma

Recruiting
View on ClinicalTrials.gov →
Summary
The study will be an effectiveness study. The study will include enrollment of a total of 20 patients with at least one PC lesion for ultrasound guided RFA to PC recurrence in the neck to assess the effectiveness in reducing patient's hypercalcemia. Patients will have surgically proven PC from prior parathyroidectomy and suspicious PC visible on ultrasound and request for treatment for uncontrolled hypercalcemia (Figure 1).
Protocol Amendment History 1 change
critical Recruitment opened 2026-04-15
Trial Details
NCT Number NCT07475780
Lead Sponsor M.D. Anderson Cancer Center
Conditions Recurrent Parathyroid Carcinoma
Enrollment 20 participants
Start Date 2026-04-09
Primary Completion 2029-04-30 (estimated)
Study Completion 2031-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-14